For example, Bifidobacterium has been shown to improve anti-tumor immunity in vivo, both alone and in combination with anti-PD-L1 immunotherapy through modulation of dendritic cell function and the subsequently improved effector function of tumor-specific CD8+ T cells [21]. The gene discussed is CD8A; the disease is neoplasm.